BRIEF published on 07/29/2025 at 07:05, 4 months 6 days ago SIG Group AG: Resilient Revenue Growth Despite Market Challenges Revenue Growth EBITDA Margin Free Cash Flow Capital Expenditures Regional Performance
PRESS RELEASE published on 07/29/2025 at 07:00, 4 months 6 days ago SIG Group AG: Solid financial results in a challenging market environment SIG Group AG reports solid financial results with 2.6% revenue growth in H1 2025 despite a challenging market environment. Full year guidance aims for 3-5% revenue growth and EBITDA margin at 24.5-25.5% Financial Results Revenue Growth EBITDA Margin Market Environment SIG Group AG
BRIEF published on 04/29/2025 at 07:05, 7 months 5 days ago SIG Group Reports Resilient Revenue Growth in Q1 2025 Revenue Growth EBITDA Margin Regional Performance 2025 Guidance Trade Tariffs
PRESS RELEASE published on 04/29/2025 at 07:00, 7 months 5 days ago SIG Group AG Q1 2025 trading update: Resilient revenue growth and solid financials SIG Group AG Q1 2025 trading update: Resilient revenue growth and solid financials. Revenue up 3.4% vs. Q1 2024. Adjusted EBITDA margin at 22.3%. Full year guidance confirmed Revenue Growth Financials SIG Group AG Guidance Q1 2025
BRIEF published on 04/08/2025 at 18:19, 7 months 26 days ago Board's Proposals Approved at SIG's 2025 AGM Shareholders Dividend Board Approval AGM 2025 Ola Rollén
PRESS RELEASE published on 04/08/2025 at 18:14, 7 months 26 days ago All proposals of the Board of Directors approved at SIG’s 2025 Annual General Meeting SIG shareholders approve all proposals at 2025 Annual General Meeting, including election of new Board members and cash dividend. Ola Rollén elected as new chair Annual General Meeting Shareholders Board Members Dividend SIG
BRIEF published on 03/19/2025 at 17:45, 8 months 16 days ago SIG Group AG Launches €625m Eurobond Amid Investment Grade Rating Capital Markets Investment Grade Debt Refinancing SIG Group Eurobond Issuance
PRESS RELEASE published on 03/19/2025 at 17:40, 8 months 16 days ago SIG issues €625m Eurobond following recent Moody’s investment grade rating SIG issues €625m Eurobond with a 3.75% annual coupon and Moody’s investment grade rating. Proceeds to refinance existing bond. Joint coordinators: BNP, Bank of America Refinancing Moody's Eurobond SIG Group AG Investment Grade Rating
BRIEF published on 02/25/2025 at 07:05, 9 months 7 days ago SIG Group AG Reports Resilient Growth and Solid Financial Performance in 2024 Adjusted EBITDA Revenue Growth Dividend Proposal 2025 Outlook Carton Business
PRESS RELEASE published on 02/25/2025 at 07:00, 9 months 7 days ago SIG Group AG: Resilient revenue growth coupled with solid financial performance SIG Group AG reports resilient revenue growth and solid financial performance in 2024. Outlook for 2025 includes 3-5% revenue growth and 24.5-25.5% EBTIDA margin. Proposed dividend of CHF 0.49 per share Revenue Growth Financial Performance Dividend Proposal SIG Group AG 2025 Outlook
Published on 12/05/2025 at 02:35, 2 hours 45 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 20 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 15 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 20 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 49 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 29 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 54 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 5 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 9 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 35 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 35 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 19 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
